Grant Submissions Sample Clauses

Grant Submissions. Subject to approval pursuant to Section 2.5.3, Institution Personnel shall have the right to submit grant applications related to the Crosswalk Project and/or disclosing any Crosswalk Information or the nature of the relationship among the Parties to any international, federal and/or state agencies or not-for-profit foundations which do not require licensing to a commercial entity; provided, however, that such Institution Personnel shall provide a draft of such grant applications to deCODE at least fifteen (15) days prior to submission to such agencies or foundations. In the event that an Institution Personnel wants to exclude from review any portions of a grant application that do not disclose any Crosswalk Information or the nature of the relationship among the Parties, then such Institution Personnel shall provide to deCODE: (i) a draft of all other portions of such grant application, including all portions disclosing any Crosswalk Information or the nature of such relationship; and (ii) a certification from the Institution Personnel submitting such grant application and Institutions' IP Project Leader that deCODE has been provided with all portions of such grant application disclosing Crosswalk Information and the nature of such relationship, and all portions reasonably necessary for deCODE to determine whether such grant application reveals a Crosswalk Invention. In such event, deCODE may request additional information as it deems reasonably necessary or desirable to make such a determination. Such grant submission shall be subject to Section 5.3. When so requested by deCODE, Institutions and Institution Personnel shall indicate on such grant application that certain proprietary business information is contained therein which
Sample 1
AutoNDA by SimpleDocs
Grant Submissions. Investigators shall have the right to submit grant applications disclosing any Research Data, except for deCODE Research Data set forth in Appendix E, or the nature of the relationship among the Parties to any international, federal, or state agencies or not-for-profit foundations which do not require licensing to a commercial entity; provided, however, that such Investigators shall provide a draft of such grant applications to deCODE at least fifteen (15) days prior to submission to such agencies or foundations. In the event that an Investigator wants to exclude from review any portions of a grant application that do not disclose any Research Data or the nature of the relationship among the Parties, then such Investigator shall provide to deCODE: (i) a draft of all other portions of such grant application, including all portions disclosing any Research Data; and (ii) a certification from the Principal Investigator and IP Project Leader that deCODE has been provided with all portions of such grant application -10- 47 disclosing Research Data and all portions reasonably necessary for deCODE to determine whether such grant application reveals a potentially patentable Invention. In such event, deCODE may request additional information as it deems reasonably necessary or desirable to make such a determination. Such grant submission shall be subject to Section 6.3. When so requested by deCODE, Institution and Investigators shall indicate on such grant application that certain proprietary business information is contained therein which is not subject to disclosure under the Freedom of Information Act, and shall request that such information be treated as confidential.
Sample 1
Grant Submissions. Investigators shall have the right to submit grant applications related to the Study and/or disclosing any Study Data, except for deCODE Research Data set forth on Appendix E of the Sponsored Research Agreement, deCODE Study Data set forth in Appendix B, or the nature of the relationship among the Parties to any international, federal or state agencies or not-for-profit foundations which do not require licensing to a commercial entity; provided, however, that such Investigators shall provide a draft of such grant applications to deCODE at least fifteen (15) days prior to such submission to such agencies or foundations. In the event that an Investigator wants to exclude from review any portions of a grant application that does not disclose any such Study Data, Research Data or the nature of the relationship among the Parties, then such Investigator shall provide to deCODE: (a) a draft of all other portions of such grant application, including all portions disclosing any Study Data or Research Data; and (b) a certification from the Principal Investigator and IP Project Leader that deCODE has been provided with all portions of such grant application disclosing Study Data or Research Data and all portions reasonably necessary for deCODE to determine whether such grant
Sample 1

Related to Grant Submissions

  • FINRA Submissions For a period of 60 days following the effective date of the Registration Statement, in the event any person or entity (regardless of any FINRA affiliation or association) is engaged to assist the Company in its search for a merger candidate or to provide any other merger and acquisition services, or has provided or will provide any investment banking, financial, advisory and/or consulting services to the Company, the Company agrees that it shall promptly provide to FINRA (via a FINRA submission), the Representative and its counsel a notification prior to entering into the agreement or transaction relating to a potential Business Combination: (i) the identity of the person or entity providing any such services; (ii) complete details of all such services and copies of all agreements governing such services prior to entering into the agreement or transaction; and (iii) justification as to why the value received by any person or entity for such services is not underwriting compensation for the Offering. The Company also agrees that proper disclosure of such arrangement or potential arrangement will be made in the tender offer materials or proxy statement, as applicable, which the Company may file in connection with the Business Combination for purposes of offering redemption of shares held by its stockholders or for soliciting stockholder approval, as applicable.

  • Regulatory Submissions From and after the Effective Date, NVS will[***] be responsible for (a) preparing, filing, and submitting, directly or through its Affiliates and permitted Sublicensees, all Regulatory Submissions for all Products in the Territory, and each material amendment or update thereto, in its name other than Jointly-Agreed Regulatory Submissions; and (b) interfacing, corresponding and meeting with Regulatory Authorities relating to Regulatory Submissions in the Territory for such Products; provided, that Regulatory Submissions and correspondence made to, and meetings held with, the FDA and EMA with respect to (i) [***] or (ii) [***] in each of (i) and (ii), will be prepared or conducted, as applicable, in collaboration with a representative from HMI’s regulatory team in accordance with this Article 7 (Regulatory Affairs); provided further that in all cases, such rights shall expressly exclude and not apply with Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Confidential Treatment Requested by Homology Medicines, Inc. respect to any data in Regulatory Submissions, correspondence, or meetings relating to any Other Components. Subject to Section 7.6 (Transfer of U.S. BLA for In-Vivo [***] Products), all Regulatory Approvals and Pricing Approvals for Products will be [***] owned by [***]. For all Products, NVS will timely inform HMI regarding the submission, receipt or denial of Regulatory Approval for such Product obtained or denied; provided, however, that NVS will inform HMI of such event prior to public disclosure of such event by NVS.

  • Performance of Material Contracts Perform and observe all the terms and provisions of each Material Contract to be performed or observed by it, maintain each such Material Contract in full force and effect, enforce each such Material Contract in accordance with its terms, take all such action to such end as may be from time to time requested by the Administrative Agent and, upon request of the Administrative Agent, make to each other party to each such Material Contract such demands and requests for information and reports or for action as any Loan Party or any of its Subsidiaries is entitled to make under such Material Contract, and cause each of its Subsidiaries to do so, except, in any case, where the failure to do so, either individually or in the aggregate, could not be reasonably likely to have a Material Adverse Effect.

  • Timeliness of Submitting Orders a. You are obliged to date and indicate the time of receipt of all orders you receive from your customers and to transmit promptly all orders to us in time to provide for processing at the price next determined after receipt by you, in accordance with the Prospectuses. You are not to withhold placing with us orders received from any customers for the purchase of shares. You shall not purchase shares through us except for the purpose of covering purchase orders already received by you, or for your bona fide investment.

  • Auction Schedule; Method of Submission of Orders (a) The Fund and the Auction Agent shall conduct Auctions for Preferred Shares in accordance with the schedule set forth below. Such schedule may be changed at any time by the Auction Agent with the consent of the Fund, which consent shall not be withheld unreasonably. The Auction Agent shall give notice of any such change to BD. Such notice shall be received prior to the first Auction Date on which any such change shall be effective. Time Event ---- -----

  • Notice of Material Actions / Change in Control The Sub-Adviser will keep the Trust and the Adviser informed of developments relating to its duties as subadviser of which the Sub-Adviser has, or should have, knowledge that would materially affect the Fund. The Sub-Adviser will promptly notify the Adviser in writing of the occurrence of any of the following events (i) it is served or otherwise receives notice of, or is threatened with, any material action, suit, proceeding, inquiry or investigation, at law or in equity, before or by any court, governmental, administrative or self-regulatory agency, or public board or body, involving the affairs of the Fund and (ii) any change in the partners of the Sub-Adviser or in the actual control or management of the Sub-Adviser or change in the portfolio manager(s) primarily responsible for the day-to-day management of the Allocated Portion.

  • Maintenance of Review Materials It will maintain copies of any Review Materials, Review Reports and other documents relating to a Review, including internal correspondence and work papers, for a period of at least two years after any termination of this Agreement.

  • Claims for Benefits All claims by the Executive for benefits under this Agreement shall be directed to and determined by the Board and shall be in writing. Any denial by the Board of a claim for benefits under this Agreement shall be delivered to the Executive in writing and shall set forth the specific reasons for the denial and the specific provisions of this Agreement relied upon. The Board shall afford a reasonable opportunity to the Executive for a review of the decision denying a claim and shall further allow the Executive to appeal to the Board a decision of the Board within sixty (60) days after notification by the Board that the Executive’s claim has been denied.

  • Review of Materials During the term of this Agreement, Client shall ensure that all prospectuses, statements of additional information, registration statements, proxy statements, reports to shareholders, advertising and sales literature or other materials prepared for distribution to Fund shareholders or the public, which refer to the Subadviser in any way, prepared by employees or agents of Client or its affiliates are consistent with information previously provided by Subadviser. Subadviser shall promptly notify the Client of any changes to information pertaining to the Subadviser and stated in the materials described in this Section 6(g).

Time is Money Join Law Insider Premium to draft better contracts faster.